Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis

NCT00621400 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Amyloidosis

Interventions

DRUG: Lenalidomide
DRUG: Melphalan
DRUG: Dexamethasone

Sponsor

Nantes University Hospital